Leigh D, McBurney A, McIlwain H
Br J Psychiatry. 1981 Aug;139:153-6. doi: 10.1192/bjp.139.2.153.
Erythrocyte transketolase activity and the effect of adding thiamine pyrophosphate (% TPP effect) were measured in subjects suffering from Wernicke-Korsakoff syndrome both before and during treatment with thiamine and/or thiamine tetrahydrofurfuryldisulphide (TTFD). Transketolase activity was significantly lower in untreated patients than in healthy volunteers. Treatment with either thiamine or with TTFD restored enzyme levels to control values but TTFD produced a greater increase than thiamine in enzyme activity. In a group of seven patients there was no correlation between duration of TTFD therapy and either increase in erythrocyte transketolase activity or % decrease in the TPP effect. However, when three patients were followed at intervals during treatment with TTFD, their erythrocyte transketolase increased progressively. Neither thiamine nor TTFD produced clinical improvement in the mental symptoms of Wernicke-Korsakoff psychosis unless administered early in the course of the disease.
在患有韦尼克-科尔萨科夫综合征的患者中,在使用硫胺素和/或四氢糠基二硫化硫胺素(TTFD)治疗之前和期间,均测量了红细胞转酮醇酶活性以及添加焦磷酸硫胺素后的效果(%TPP效应)。未治疗患者的转酮醇酶活性显著低于健康志愿者。使用硫胺素或TTFD治疗均可使酶水平恢复至对照值,但TTFD使酶活性的增加幅度大于硫胺素。在一组7名患者中,TTFD治疗持续时间与红细胞转酮醇酶活性增加或TPP效应降低百分比之间均无相关性。然而,当在TTFD治疗期间对3名患者进行定期随访时,他们的红细胞转酮醇酶逐渐增加。除非在疾病早期给药,否则硫胺素和TTFD均未使韦尼克-科尔萨科夫精神病的精神症状出现临床改善。